XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 99 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $158,000 | -8.7% | 35,100 | 0.0% | 0.00% | – |
| Q4 2020 | $173,000 | -16.8% | 35,100 | 0.0% | 0.00% | – |
| Q3 2020 | $208,000 | +123.7% | 35,100 | 0.0% | 0.00% | – |
| Q2 2020 | $93,000 | +132.5% | 35,100 | +71.2% | 0.00% | – |
| Q1 2020 | $40,000 | -72.4% | 20,500 | 0.0% | 0.00% | – |
| Q4 2019 | $145,000 | -28.2% | 20,500 | 0.0% | 0.00% | – |
| Q3 2019 | $202,000 | +2.0% | 20,500 | +18.5% | 0.00% | – |
| Q2 2019 | $198,000 | – | 17,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|